![]() ![]() We recommend the following clinical targets for CGM blood glucose readings for most people who have type 1 or type 2 diabetes The second step was to decide on clinical targets for these metrics, so health care professionals and patients would know what values to strive for.Īnother international consensus group convened, and the resulting report, Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range, was published in Diabetes Care in 2019. The metrics include time in range (TIR)-time in the target blood glucose range of 70 to 180 mg/dL-as well as time below range (TBR) and time above range (TAR). These metrics are included in the American Diabetes Association (ADA) Standards of Medical Care in Diabetes-2020. It took until 2019 to develop the 10 standardized, clinically useful metrics for continuous glucose monitoring. The effort began with an international consensus meeting in 2012. Over the past decade, the Park Nicollet International Diabetes Center and many investigators, including myself, have been working on this issue. How did the group develop these targets?Ī: The first step was to develop standardized continuous glucose monitoring metrics. Q: You were part of an international group that recommended clinical targets for people who have diabetes and use CGMs. Meeting these clinical targets can help improve diabetes management and lower the risk for diabetes complications. An international group of experts on continuous glucose monitoring developed the targets, which were published in 2019 and focus on the amount of time a person’s blood glucose levels are within specific ranges. Bergenstal, MD, talks about the latest clinical targets for people with diabetes who use continuous glucose monitors (CGMs). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |